The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet
ConclusionWhen provided in the context of a high-Cho diet, these findings reveal previously unrecognized hepato-inflammatory effects of sitagliptin that are accompanied by evidence of hepatic necrosis and mononuclear cell infiltration.
Source: Inflammation Research - Category: Research Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Diets | Fatty Liver Disease (FLD) | Heart | Incretin Therapy | Insulin | Januvia | Liver | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Research | Study | Urology & Nephrology